Innovative ETFs Content Hub Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene By Max ChenNovember 1, 2019
Disruptive Technology Content Hub How ETF Investors Could Enhance a Portfolio with Disruptive Innovative Companies By Max ChenOctober 1, 2019
Disruptive Technology Content Hub Focusing on Disruptive Innovation for Changing Markets By Max ChenSeptember 30, 2019
Innovative ETFs Content Hub Drug Pricing Reforms Keep Pressure on Biotech, Healthcare ETFs By Max ChenSeptember 26, 2019
Innovative ETFs Content Hub ACADIA Pharmaceuticals Help Lift Biotech ETFs By Max ChenSeptember 9, 2019
Beyond Basic Beta Content Hub 8 ETFs to Capture Opportunities in Healthcare Sector By Max ChenAugust 22, 2019
Innovative ETFs Content Hub Healthcare Providers ETF Breaks Out After White House Ends Drug Rebate Rule By Max ChenJuly 11, 2019
Innovative ETFs Content Hub Biotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing Rule By Max ChenJuly 9, 2019
Beyond Basic Beta Content Hub ETF of the Week: Robo Global Healthcare Technology and Innovation ETF (HTEC) By Ben HernandezJuly 9, 2019
Alternatives Content Hub Sector ETFs Most at Risk of Earning Disappointments Ahead By Max ChenJuly 2, 2019
Disruptive Technology Content Hub 4 ARK ETFs to Help Investors Access Innovative Disruptors By Max ChenJune 21, 2019
Innovative ETFs Content Hub Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal By Max ChenJune 17, 2019
Leveraged & Inverse Content Hub Health Care ETFs Could be Cure for Trade War Blues By Ben HernandezMay 29, 2019
